tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Akoya Biosciences backs FY23 revenue view $95M-$98M, consensus $96.38M

The company said, “The Company, based on its current plans and initiatives, continues to expect full year 2023 revenue in the range of $95-98 million.”

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on AKYA:

Disclaimer & DisclosureReport an Issue

1